ScholarLens Back to search
2011•Unpublished venueRequires access

Bridging therapies and liver transplantation in acute liver failure

Minna Ilmakunnas, Meri Tuulikki Koivusalo

Open publisher page 1 citations

Abstract

acute liver failure is a life-threatening condition in the absence of liver transplantation option. the aetiology of liver failure is the most important factor determining the probability of native liver recovery and prognosis of the patient. extracorporeal liver assist devices like Mars (Molecular adsorbent recirculating system) may buy time for native liver recovery or serve as bridging therapy to liver transplantation, with reduced risk of cerebral complications. Mars treatment may alleviate hepatic encephalopathy even in patients with a completely necrotic liver. taking this into account, better prognostic markers than hepatic encephalopathy should be used to assess the need for liver transplantation in acute liver failure.

About this research paper

What this paper is about

acute liver failure is a life-threatening condition in the absence of liver transplantation option. the aetiology of liver failure is the most important factor determining the probability of native liver recovery and prognosis of the patient. extracorporeal liver assist devices like Mars (Molecular adsorbent recirculating system) may buy time for native liver recovery or serve as bridging therapy to liver transplantation, with reduced risk of cerebral complications. Mars treatment may alleviate hepatic encephalopathy even in patients with a completely necrotic liver. taking this into account, better prognostic markers than hepatic encephalopathy should be used to assess the need for liver transplantation in acute liver failure.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

acute liver failure is a life-threatening condition in the absence of liver transplantation option. the aetiology of liver failure is the most important factor determining the probability of native liver recovery and prognosis of the patient. extracorporeal liver assist devices like Mars (Molecular adsorbent recirculating system) may buy time for native liver recovery or serve as bridging therapy to liver transplantation, with reduced risk of cerebral complications. Mars treatment may alleviate hepatic encephalopathy even in patients with a completely necrotic liver. taking this into account, better prognostic markers than hepatic encephalopathy should be used to assess the need for liver transplantation in acute liver failure.

Key concepts: Liver transplantation, Hepatic encephalopathy, Liver failure, Medicine, Encephalopathy, Extracorporeal, Etiology, Transplantation

Back to paper searchBrowse research topicsOriginal source
Bridging therapies and liver transplantation in acute liver failure — Research Paper | ScholarLens